DEA Investigation Defense for Prescribers and Pharmacies

Who This Page Is For

Physicians, nurse practitioners, and physician assistants who prescribe controlled substances. Pharmacists and pharmacy owners who dispense them. Owners and managers of pain, weight loss, addiction treatment, and telehealth practices. Office staff who handled prescriptions, intake, or cash.

Controlled substance prescribing is a stated federal enforcement priority. The Justice Department's National Fraud Enforcement Division lists controlled-substance diversion and opioid prescribing within its second priority, healthcare fraud. DOJ's June 2026 Health Care Fraud Takedown charged 36 defendants with illegal opioid distribution, and 28 of them were medical professionals. TRAC data for 2026 shows prosecutors charging about 563 defendants a month under 21 U.S.C. § 841 and about 246 a month under § 846.

How DEA Diversion Cases Start

• Prescription data. State prescription monitoring program data and DEA distribution reports flag prescribers and pharmacies whose volume, dosing, or patient mix stands out.
• Inspections. DEA Diversion Investigators arrive with a notice of inspection or an administrative inspection warrant under 21 U.S.C. § 880 and ask for inventories, dispensing logs, and prescriptions.
• Administrative subpoenas. DEA issues subpoenas for records under 21 U.S.C. § 876 without going to a grand jury.
• Undercover patients. Agents or informants pose as patients and record the visit.
• Wholesaler cutoffs. A distributor stops shipping to a pharmacy after its own suspicious order review.
• Complaints and cooperators. Former employees, other pharmacies, and patients who were arrested.
• The day of action. A search warrant, an Immediate Suspension Order, and a request to sign a surrender form, often in the same visit.

When a Prescription Becomes a Federal Crime

21 U.S.C. § 841(a)(1) makes it a crime to knowingly or intentionally distribute or dispense a controlled substance "except as authorized." A registrant is authorized only within limits. Under 21 C.F.R. § 1306.04(a), a prescription is effective only if it is issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. A prescription outside that standard is not a prescription in the eyes of the law, and the government charges it as drug distribution.

The Supreme Court narrowed that theory in Ruan v. United States (2022). Once a prescriber produces evidence that the prescribing was authorized, the government must prove beyond a reasonable doubt that the prescriber knowingly or intentionally acted in an unauthorized manner. Malpractice is not a crime. A prescriber who believed in good faith, even mistakenly, that a prescription served a legitimate medical purpose has a defense the jury must weigh.

The Other Charges in Prescriber and Pharmacy Cases

• Conspiracy, 21 U.S.C. § 846. Same maximum penalty as the object offense. Used to tie prescribers, pharmacists, owners, recruiters, and staff into one case.
• Registration and record offenses, 21 U.S.C. § 843. Using a revoked, suspended, expired, or borrowed registration number; obtaining controlled substances by misrepresentation or fraud; and putting false material information in required records. Up to 4 years per count.
• Recordkeeping violations, 21 U.S.C. § 842. Refusing or negligently failing to keep required records carries a civil penalty of up to $10,000 per violation (adjusted for inflation), and a knowing violation can be charged as a crime carrying up to one year.
• Drug-involved premises, 21 U.S.C. § 856. Charged against clinic and pharmacy owners in pill mill cases. Up to 20 years.
• Healthcare fraud overlay. When Medicare, Medicaid, or a private insurer paid for the visits or the prescriptions, the government adds health care fraud counts, and kickback counts if anyone was paid for referrals or prescriptions.

Penalties and Sentencing

For Schedule II substances, § 841(b)(1)(C) sets a maximum of 20 years per count. If death or serious bodily injury results from use of the substance, the range becomes 20 years to life, with a 20-year mandatory minimum. Schedule III carries up to 10 years, Schedule IV up to 5 years, and Schedule V up to 1 year.

The sentencing guidelines drive the actual sentence. USSG § 2D1.1 sets the offense level by drug quantity, and in prescriber cases the government usually counts every pill on every prescription it calls unlawful. Prosecutors also seek two levels under § 3B1.3 for abuse of a position of trust or use of a special skill. The quantity number is where sentencing is won or lost, and it comes from a prescription-by-prescription review that the defense has to do on its own.

Your DEA Registration: The Administrative Track

The registration case runs separately from any criminal case and moves faster.

• Order to Show Cause. Under 21 U.S.C. § 824(c), DEA must serve an order stating the basis for revocation or denial and offering the chance to submit a corrective action plan. You have 30 days from receipt to request a hearing before an administrative law judge. Silence is default.
• Immediate Suspension Order. Under § 824(d), DEA can suspend a registration on the day of service if it finds an imminent danger to public health or safety. The suspension lasts until the proceeding ends.
• The hearing. DEA argues that continued registration is inconsistent with the public interest under the factors in 21 U.S.C. § 823(g)(1): the state board's recommendation, experience dispensing, conviction record, compliance with controlled substance laws, and other conduct that may threaten public health and safety.
• Voluntary surrender. Investigators often hand over DEA Form 104 during an inspection. A signed surrender takes effect when DEA receives it, does not stop a criminal investigation, and is treated as a surrender for cause. Do not sign it before counsel reviews it.

Pharmacists: Corresponding Responsibility and Red Flags

The regulation places a corresponding responsibility on the pharmacist who fills a prescription. DEA and prosecutors build pharmacy cases on red flags the pharmacy allegedly ignored: patients traveling long distances, cash payment, the same drug combinations across many patients, early refill requests, groups of patients arriving together, and a small number of prescribers writing most of the controlled prescriptions. The defense question is whether the pharmacist identified the issue, resolved it with the prescriber or the patient, and documented the resolution. Pharmacy owners face added exposure for the dispensing decisions of every pharmacist they employ. If your pharmacy also compounds, see our page on compounding pharmacy defense.

Parallel Exposure: State Board, Medicare, and Kickbacks

• State licensing boards. Practitioner registration depends on state authority. A license suspension is a ground for DEA revocation under § 824(a)(3).
• Medicare and Medicaid. A felony conviction relating to the unlawful prescribing or dispensing of a controlled substance requires exclusion for at least five years under 42 U.S.C. § 1320a-7(a)(4). Exclusion is itself a ground for DEA revocation.
• Kickbacks. Payments to marketers or recruiters for prescriptions bring Anti-Kickback Statute exposure when federal programs pay, and EKRA exposure for laboratories and treatment facilities. See anti-kickback defense.

How These Cases Are Defended

• Knowledge and intent under Ruan. The patient file, the treatment agreements, the monitoring program queries, and the referrals show what the prescriber knew and believed.
• Independent clinical review. Government experts often review a small sample and project it across the practice. A qualified independent expert reviews the files the government chose and the ones it ignored.
• Quantity. Every prescription the government cannot prove unlawful comes out of the guideline calculation.
• Undercover visits. Recordings often show a real evaluation, a refused request, or a referral the government's summary leaves out.
• The registration case. A timely hearing request, a credible corrective action plan, and coordination with the state board keep the practice or pharmacy alive while the criminal case is fought.
• Timing. The strongest work happens before indictment, when the government is still deciding whether the case is a registration matter, a civil matter, or a criminal one. See target letter and pre-indictment defense.

What to Do Now

1. Do not give an interview. Be courteous, take the investigators' cards, and decline to discuss patients or prescriptions without counsel.
2. Do not sign a surrender form. A Form 104 can be discussed later. It cannot easily be undone.
3. Calendar the deadline. An Order to Show Cause starts a 30-day clock to request a hearing.
4. Preserve everything. Patient files, prescription records, dispensing logs, inventories, monitoring program queries, emails, and texts. Do not alter or complete records after the fact.
5. Call federal defense counsel. The criminal, registration, licensing, and Medicare tracks need one strategy from the first day.

For street-level and trafficking conspiracy cases, see federal drug trafficking defense.

Who Handles Your Case

Aaron M. Cohen has defended federal healthcare fraud and controlled substance cases for more than 30 years. Our team includes a federal investigations consultant who is a former FBI Supervisory Special Agent and a sentencing strategist who works on mitigation and quantity analysis from the start of the case. We represent prescribers, pharmacists, and pharmacy owners in federal investigations and prosecutions nationwide.